Literature DB >> 8587291

Clinical predictors of chronic renal allograft rejection.

Z A Massy1, C Guijarro, B L Kasiske.   

Abstract

Among both immune and nonimmune factors implicated in the pathogenesis of chronic renal allograft rejection, acute rejection episodes represent a strong and consistent predictor. However, all acute rejection episodes are not equally predictive of chronic renal allograft rejection. Early and mild acute rejection episodes do not usually cause chronic renal allograft rejection. On the other hand, late and severe acute rejection episodes occurring more than one year after transplantation are particularly strong predictors of chronic renal allograft rejection. The number of HLA mismatches is a risk factor, but its influence may not be independent of acute rejection and other risk factors. Proteinuria and recently hypoalbuminemia are also independent risk factors for chronic renal allograft rejection. However, whether these nonimmune factors are merely the result of chronic renal allograft rejection, or whether they contribute to the pathogenesis of renal injury in chronic renal allograft rejection is yet unclear. Better HLA matching, new strategies to decrease the severity of acute rejection, and measures to prevent late acute rejection, as well as prospective evaluation of the therapies to reduce proteinuria and other nonimmune risk factors for chronic renal allograft rejection are needed.

Entities:  

Mesh:

Year:  1995        PMID: 8587291

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  5 in total

1.  Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.

Authors:  L C Paul; J Muralidharan; S A Muzaffar; E H Manting; J F Valentin; E de Heer; M Kashgarian
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 2.  Renal transplant rejection markers.

Authors:  Wilfried Gwinner
Journal:  World J Urol       Date:  2007-09-05       Impact factor: 4.226

3.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

4.  Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective.

Authors:  Stephen J Walters; Malcolm Whitfield; Ronald L Akehurst; James B Chilcott
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial.

Authors:  Lena Schiffer; Mario Schiffer; Saskia Merkel; Anke Schwarz; Michael Mengel; Christopher Jürgens; Christoph Schroeder; Alexander A Zoerner; Kerstin Püllmann; Verena Bröcker; Jan U Becker; Maximilian E Dämmrich; Jana Träder; Anika Grosshennig; Frank Biertz; Hermann Haller; Armin Koch; Wilfried Gwinner
Journal:  Trials       Date:  2012-10-26       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.